Galderma研究显示,60%的减肥药物使用者寻求对皮肤问题的医学和美学综合支持。 Galderma study shows 60% of weight loss medication users seek combined medical-aesthetic support for skin issues.

Galderma对减肥药物的新研究显示,通过药物减肥的病人中有60%对医疗与美学支持相结合的服务表现出兴趣。 Galderma's new research on weight loss medications reveals that 60% of patients who lose weight through medication show interest in services that combine medical and aesthetic support. 涉及1 000多名受访者的研究发现,脸部和颈部皮肤下降是一个常见问题,通常注意到3-6个月的后期治疗。 The study, involving over 1,000 respondents, found that sagging skin on the face and neck is a common issue, typically noticed 3-6 months post-treatment. 在IMCAS 2025年大会上,Galderma将提出管理这些审美问题的指导方针,解决随着处方减肥药物使用增加而日益增加的需要。 At the IMCAS 2025 congress, Galderma will present guidelines for managing these aesthetic concerns, addressing a growing need as prescription weight loss drug use increases.